RUSSO, GIULIA
 Distribuzione geografica
Continente #
AS - Asia 5.048
NA - Nord America 3.660
EU - Europa 3.572
SA - Sud America 684
AF - Africa 131
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.104
Nazione #
US - Stati Uniti d'America 3.501
SG - Singapore 2.132
RU - Federazione Russa 1.423
IT - Italia 1.163
CN - Cina 1.038
VN - Vietnam 924
BR - Brasile 546
HK - Hong Kong 358
DE - Germania 180
FR - Francia 170
JP - Giappone 139
FI - Finlandia 137
IN - India 93
CA - Canada 86
IE - Irlanda 86
GB - Regno Unito 84
NL - Olanda 77
UA - Ucraina 64
KR - Corea 58
AR - Argentina 50
MX - Messico 42
BD - Bangladesh 39
SE - Svezia 39
CI - Costa d'Avorio 38
PH - Filippine 37
ID - Indonesia 30
ZA - Sudafrica 30
PL - Polonia 29
EC - Ecuador 28
ES - Italia 25
IQ - Iraq 25
PK - Pakistan 24
TR - Turchia 23
AT - Austria 21
TW - Taiwan 21
TH - Thailandia 20
CO - Colombia 15
PT - Portogallo 15
VE - Venezuela 14
MA - Marocco 13
IR - Iran 11
UZ - Uzbekistan 10
BG - Bulgaria 9
CL - Cile 9
PY - Paraguay 9
SA - Arabia Saudita 9
TN - Tunisia 9
PE - Perù 7
CR - Costa Rica 6
EG - Egitto 6
KE - Kenya 6
AU - Australia 5
GR - Grecia 5
IL - Israele 5
JO - Giordania 5
LB - Libano 5
NP - Nepal 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
DZ - Algeria 4
GT - Guatemala 4
JM - Giamaica 4
LT - Lituania 4
RS - Serbia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BB - Barbados 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LV - Lettonia 3
MY - Malesia 3
NG - Nigeria 3
NO - Norvegia 3
BE - Belgio 2
CG - Congo 2
CY - Cipro 2
DK - Danimarca 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
KH - Cambogia 2
LK - Sri Lanka 2
MT - Malta 2
MW - Malawi 2
MZ - Mozambico 2
NI - Nicaragua 2
PA - Panama 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
Totale 13.073
Città #
Singapore 1.043
San Jose 539
Chandler 386
Hong Kong 343
Moscow 336
Beijing 273
Naples 270
Ho Chi Minh City 241
Santa Clara 219
Ashburn 206
Hefei 192
Hanoi 176
Dong Ket 130
The Dalles 128
Napoli 110
Millbury 105
Tokyo 104
Lauterbourg 102
Council Bluffs 87
Los Angeles 84
Nanjing 70
Princeton 70
Rome 58
Orta di Atella 56
Jacksonville 52
Munich 51
Boston 50
Des Moines 50
Redondo Beach 46
Amsterdam 44
São Paulo 41
Ottawa 40
Buffalo 38
Seoul 38
Turku 38
Wilmington 38
Da Nang 36
Dallas 35
Haiphong 35
Orem 35
Milan 32
Dublin 29
Helsinki 27
New York 25
Seattle 24
Lawrence 23
Rio de Janeiro 22
Frankfurt am Main 21
Kochi 21
Shenyang 21
Biên Hòa 20
Chicago 20
Mexico City 19
Cagliari 18
Warsaw 18
Nuremberg 17
Pozzuoli 17
Houston 16
Hải Dương 15
Montreal 15
Tianjin 15
Toronto 15
Baghdad 13
Falkenstein 13
Guangzhou 13
Jiaxing 13
Redwood City 13
San Francisco 13
Campinas 12
Chennai 12
Formia 12
Lappeenranta 12
London 12
Phoenix 12
Poplar 12
Atlanta 11
Bangkok 11
Belo Horizonte 11
Brooklyn 11
Denver 11
Nocera Inferiore 11
Shanghai 11
Can Tho 10
Dhaka 10
Guayaquil 10
Hebei 10
Nanchang 10
Vienna 10
Brasília 9
Norwalk 9
Quito 9
Stockholm 9
Bagnoli Irpino 8
Bologna 8
Caserta 8
Goiânia 8
Palermo 8
Salerno 8
Santo André 8
Guarulhos 7
Totale 6.843
Nome #
- T.M. Devlin, Biochimica con aspetti clinico-farmaceutici, EdiSES, 2013 231
Integrated genomics identifies MiR-181/TFAM pathway as a critical driver of drug resistance in melanoma 212
Vitamin C enhanced erastin-induced ferroptosis in drug-resistant colorectal cancer cells and in CAM-derived xenografts 167
Cysteine Prevents the Reduction in Keratin Synthesis Induced by Iron Deficiency in Human Keratinocytes 166
Combination therapy with β-carotene+5-FU to overcome uL3-mediated drug resistance in p53 deleted colon cancer cells 162
Development and Nanoparticle-Mediated Delivery of Novel MDM2/MDM4 Heterodimer Peptide Inhibitors to Enhance 5-Fluorouracil Nucleolar Stress in Colorectal Cancer Cells 162
Antiproliferative Effects of the Aptamer d(GGGT) 4 and Its Analogues with an Abasic-Site Mimic Loop on Different Cancer Cells 160
Targeting SLC7A11/xCT counteracts uL3mediated colorectal cancer drug resistance in 2D cell culture model and in ovo CAM xenograft 159
The ‘‘Janus face” of the thrombin binding aptamer: Investigating the anticoagulant and antiproliferative properties through straightforward chemical modifications 151
TITOLO: ANTICORPO ANTI CISTATIONINA BETA SINTASI FOSFORILATA E USO DELLO STESSO 147
Human rpL3 plays a crucial role in cell response to nucleolar stress induced by 5-FU and L-OHP 146
Backbone modified TBA analogues endowed with antiproliferative activity 146
Role of uL3 in Multidrug Resistance in p53-Mutated Lung Cancer Cells 146
Combining β-Carotene with 5-FU via Polymeric Nanoparticles as a Novel Therapeutic Strategy to Overcome uL3-Mediated Chemoresistance in p53-Deleted Colorectal Cancer Cells 143
Urothelium muscarinic activation phosphorylates CBS Ser227 via cGMP/PKG pathway causing human bladder relaxation through H 2 S production 142
Role of uL3 in the crosstalk between nucleolar stress and autophagy in colon cancer cells 141
Discovery of a Novel Small Molecule Inhibitor Targeting the Frataxin/Ubiquitin Interaction via Structure-Based Virtual Screening and Bioassays 140
β3 Relaxant Effect in Human Bladder Involves Cystathionine γ-Lyase-Derived Urothelial Hydrogen Sulfide 139
"Alternative splicing and nonsense-mediated mRNA decay (NMD) in the regulation of mammalian ribosomal protein expression 138
UL3 mediated nucleolar stress pathway as a new mechanism of action of antiproliferative G-quadruplex TBA derivatives in colon cancer cells 138
uL3 loss sensitize resistant p53 deleted colon cancer cells to ferroptosis 136
cis-acting sequences and trans-acting factors in the localization of mRNA for mitochondrial ribosomal proteins 134
Novel extraribosomal function of human ribosomal protein rpL3 133
BIOCHIMICA III EDIZIONE 132
5-FU targets rpL3 to induce mitochondrial apoptosis via cystathionine-β-synthase in colon cancer cells lacking p53 132
Role of rpL3 in the translational reprogramming of colon cancer cells resistant to 5-FU” 132
Ribosome-free L3 targets E2F pathway: a new p53 independent mechanism linking ribosomal stress to cancer cell proliferation 131
Engineering of seminal RNase: first steps towards the construction of chimaeric ribonucleases. In: Structure, mechanism and functions of ribonucleases. 130
Structural properties and anticoagulant/cytotoxic activities of heterochiral enantiomeric thrombin binding aptamer (TBA) derivatives 130
Therapeutic Approaches Targeting Nucleolus in Cancer. 128
Ribosomal protein uL3 targets E2F1 and Cyclin D1 in cancer cell response to nucleolar stress 128
Photo-control of cancer cell growth by benzodiazoN-substituted pyrrole derivatives 128
Human rpL3 induces G₁/S arrest or apoptosis by modulating p21 (waf1/cip1) levels in a p53-independent manner 127
G-Quadruplex aptamer T30175 and its derivatives: exploring new potential anticancer activities 125
Human rpL3 induces p21-dependent G1/S arrest or apoptosis in Calu-6 cells 124
Alternative splicing of ribosomal protein genes regulated by AS-NMD association 124
Ribosomal protein uL3 status affects translation efficiency in colorectal cancer cells 122
uL3 Regulates Redox Metabolism and Ferroptosis Sensitivity of p53-Deleted Colorectal Cancer Cells 122
Monomolecular G-quadruplex structures with inversion of polarity sites: new topologies and potentiality 122
Non-covalent strategies to functionalize polymeric nanoparticles with NGR peptides for targeting breast cancer 121
Human rpL3 induces mitochondrial apoptosis in Calu-6 cells through activation of p21 expression. 120
Fetal Myosin Isoforms May Predict Postoperative Outcome of Patients Undergoing Congenital Heart Surgery: A Proof-of-Concept Study 119
Novel extraribosomal function of human ribosomal protein rpL3 119
Role of autophagy in cancer cell response to nucleolar and endoplasmic reticulum stress 119
uL3 status influences ferroptotic cell death in p53-deleted colorectal cancer cells 118
Hybrid Lipid/Polymer Nanoparticles for Pulmonary Delivery of siRNA: Development and Fate Upon In Vitro Deposition on the Human Epithelial Airway Barrier 118
β-carotene plus 5-FU: a promising strategy to fight uL3-mediated drug resistance in colorectal cancer cells 117
MDM2/4 inhibitors as novel therapeutic strategy to enhance 5-FU induced nucleolar stress and apoptosis in colon cancer cells 117
Thrombin binding aptamer analogues containing inversion of polarity sites endowed with antiproliferative and anti-motility properties against Calu-6 cells 117
Exploring New Potential Anticancer Activities of the G-Quadruplexes Formed by [(GTG2T(G3T)3] and Its Derivatives with an Abasic Site Replacing Single Thymidine 117
A novel extraribosomal function of human rpL3 involves antitumoral activity in Calu-6 cells through p21-dependent mitochondrial apoptosis 116
Combination of 5-FU and MDM2/4 peptide inhibitors as a promising strategy to enhance 5-FU induced nucleolar stress. 115
A novel extraribosomal function of human rpL3 involves antitumoral activity in Calu-6 cells through p21-dependent mitochondrial apoptosis. 115
Enhancement of 5-FU sensitivity by the proapoptotic rpL3 gene in p53 null colon cancer cells through combined polymer nanoparticles 115
Cystine/glutamate exchanger xCT plays a critical role in uL3-mediated drug resistance 111
Subcellular localization of mRNAs encoding human ribosomal proteins 111
Novel therapeutic strategy combining β-carotene with 5-FU to overcome uL3-mediated chemoresistance in colorectal cancer cells 110
Local administration of WIN 55,212-2 reduces chronic granuloma-associated angiogenesis in rat by inhibiting NF-kappaB activation 110
Ribosomal protein uL3 is involved in translational reprogramming of 5-FU resistant colorectal cancer cells 109
Effect of phytocannabinoids in "in vitro models of Alzheimer's Disease" 109
PEGylated cationic nanoassemblies based on triblock copolymers to combine siRNA therapeutics with anticancer drugs 109
Cannabinoids reduce granuloma-associated angiogenesis in rats by controlling transcription and expression of mast cell protease-5 108
Gene modulation by tumor promoters. 107
Biologically active recombinant Prothrombin and Antithrombin III expressed in a human hepatoma/vaccinia virus system. 106
Ribosomal protein L7a binds RNA through two distinct RNA-binding domains 106
Human rpL3 induces mitochondrial apoptosis in Calu-6 cells through activation of p21 expression 106
Inhibition of granuloma-associated angiogenesis by controlling mast cell mediator release:role of mast cell protease-5 105
L3 is involved in the translational reprogramming in 5-FU chemoresistance” ABCD Meeting: From Stress Response to Tissue Development and Regeneration. 105
Ribosome biogenesis and cancer: Overview on ribosomal proteins 105
Novel Molecular Mechanisms Underlying Tumorigenesis and Innovative Therapeutic Approaches for Cancer-Fighting 104
Easy chemical modifications to explore the ‘Janus face’ of TBA: anticoagulant vs antiproliferative properties. 104
Degradazione selettiva di mRNA aberranti nella regolazione dell'espressione genica 103
S-Adenosylmethionine Increases the Sensitivity of Human Colorectal Cancer Cells to 5-Fluorouracil by Inhibiting P-Glycoprotein Expression and NF-κB Activation 101
Enhanced 5-FU-mediated activation of p53-dependent nucleolar stress by MDM2/4 peptide inhibitors in colon cancer cells 101
Ribosome-free L3 regulates cell proliferation independently of p53 by targeting E2F and inhibiting its function 101
Stable expression and purification of a secreted human recombinant prethrombin-2 and its activation to thrombin. 100
Control of human coagulation by recombinant serine proteases. 100
S-Adenosyl-L-Methionine Overcomes uL3-Mediated Drug Resistance in p53 Deleted Colon Cancer Cells 100
Post-transcriptional regulatory strategies and extraribosomal functions of human rpL3 99
β-carotene as a novel adjuvant in the therapy with 5-FU of p53 deleted colon cancer cells 98
hnRNP H1 and intronic G-runs in the splicing control of the human rpL3 gene FEBS 98
Role of uL3 in the translational reprogramming of 5-FU resistant colorectal cancer cells lacking functional p53 98
Different domains cooperate to target the human ribosomal L7a protein to the nucleus and to the nucleoli. 96
Nanoparticles sequentially decorated with polyethyleneimine and hyaluronan delivering drugs to cancer cells overexpressing CD44 receptor 96
Palmitoylethanolamide controls rMCP-5 activity by the regulation of microphtalmia-associated transcription factor. 95
5-FU targets rpL3 to induce mitochondrial apoptosis via cystathionine-b-synthase in colon cancer cells lacking p53 95
Association of alternative splicing (AS) and nonsense-mediated mRNA decay (NMD) in the post-transcriptional regulation of ribosomal protein genes 94
uL3 is a key regulator of oxidative stress response genes in multidrug resistant lung cancer cells 94
Biodegradable nanoparticles bearing amine groups as a strategy to alter surface features, biological identity and accumulation in a lung metastasis model 94
Regulatory role of rpL3 in cell response to nucleolar stress induced by Act D in tumor cells lacking functional p53 93
ALTERNATIVE SPLICING AND NONSENSE-MEDIATED MRNA DECAY REGULATE MAMMALIAN RIBOSOMAL GENE EXPRESSION 91
rpL3 mediates the cell response to nucleolar stress induced by Act D in p53 null cancer cells 91
AS-NMD in ribosomal protein gene regulation: involvment of hnRNP H1. KHSRP and Nucleophosmin/NMP 88
Easy chemical modifications to explore the ‘Janus face’ of TBA: anticoagulant vs antiproliferative properties. 88
Ribosomal Proteins Control or Bypass p53 during Nucleolar Stress 86
HUMAN L7A RIBOSOMAL PROTEIN: SEQUENCE, STRUCTURAL ORGANIZATION AND EXPRESSION OF A FUNCTIONAL GENE 85
Impact of ribosomal protein uL3 status on cystine/glutamate antiporter xCT expression 85
Novel uL3-based Therapeutic Approaches to Treat Colon Cancer Devoid of p53 85
The 3'-untranslated region directs ribosomal protein-encoding mRNAs to specific cytoplasmic regions 84
Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat chronic granulomatous inflammation 83
Totale 11.886
Categoria #
all - tutte 37.916
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.916


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021149 0 0 0 0 0 0 0 0 0 0 16 133
2021/2022499 2 4 6 9 7 40 6 16 76 30 82 221
2022/2023867 106 85 22 78 89 111 5 99 163 43 44 22
2023/2024471 28 81 38 11 20 50 23 74 11 13 74 48
2024/20253.750 130 208 15 185 157 244 425 245 272 315 1.221 333
2025/20266.309 672 628 685 592 1.150 201 605 467 817 413 79 0
Totale 13.495